Delivery Order SPE2DB24D2205-SPE2DB25FEHQX
- Not listed
- The Defense Logistics Agency awarded a $24,175.31 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of August 1, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies brand-name medications, generic drugs, vaccines,...
- The Defense Logistics Agency awarded a delivery order valued at $3,675.77 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes. This contract, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was made competitively and reflects AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is the company's...
- The Defense Logistics Agency awarded a delivery order valued at $11,704.73 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the company's larger pharmaceutical supply framework with the federal government. The product will be performed and delivered from AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $46,654.02 to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/mL syringes. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under the...
- The Defense Logistics Agency awarded a $7,141.26 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of May 7, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single procurement action under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Orencia 125 mg/mL syringes valued at $7,796.46. This non-competitive delivery order is issued under a firm fixed price structure with a completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued against AmerisourceBergen's Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,282.52 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed-price delivery order, which is expected to be completed by September 9, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio for federal medical procurement. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $10,711.89 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orencia 125 mg/ml syringes. The contract carries a firm fixed price structure with no set-aside designation, reflecting competitive procurement procedures. The award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a $5,372.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a single delivery order for pharmaceutical supply under the company's existing federal contracting vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, supplying the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orencia 125 mg/mL syringes. The $29,919.30 firm-fixed-price contract has an ultimate completion date of September 10, 2024. AmerisourceBergen provides pharmaceutical and medical products to support various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This award is part of...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHQXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $31,595.86 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of September 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.6k | 9/16/25 |